Molecular Matrix, Inc. ("MMI"), a California company, was incorporated in August 2011 as a preclinical stage biotechnology company that is developing an innovative bone regeneration technology (Osteop...
Molecular Matrix, Inc. ("MMI"), a California company, was incorporated in August 2011 as a preclinical stage biotechnology company that is developing an innovative bone regeneration technology (Osteopoietic SystemsTM). MMI has completed a 510(k) submission to the U.S. Food and Drug Administration for clearance of Osteo-PTM Bone Graft Substitute (Osteo-PTM BGS).